SBIR Phase I: An Innovative and Cost Effective Biotechnology for In-situ Treatment of Methyl Tert-Butyl Ether (MTBE)

SBIR 第一阶段：用于原位处理甲基叔丁基醚 (MTBE) 的创新且具有成本效益的生物技术

• 批准号: 0319959
• 负责人: Fatemeh Shirazi
• 金额: $ 9.99万
• 依托单位: STRATUM ENGINEERING INC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-07-01 至 2004-04-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0319959&HistoricalAwards=false
• 关键词: SBIR; Phase; Innovative; Cost; Effective

This Small Business Innovation Research (SBIR) Phase I project is to develop and demonstrate unique features of a novel biotechnology process for in-situ bioremediation of Methyl Tert-Butyl Ether (MTBE) in groundwater. Major problems with in-situ bioremediation of MTBE include the inability to establish high densities of bacteria, the inability to maintain contact between the degrading bacteria and MTBE, and the upsets and losses of bacteria. The primary objective of this Phase I project is to evaluate degradation performance of the biological permeable barrier [BPB] using Bio-beads as the reactive material. It is anticipated that MTBE will be effectively biodegraded to non-detectable levels. The commercial application of this project is in the area of bioremediation. Success of the work is expected to have major impact on the various environmental problems linked to contaminated sites both in the public and private sectors.

这个小企业创新研究（SBIR）第一阶段项目是开发和展示一种新的生物技术工艺的独特功能，用于地下水中甲基叔丁基醚（MTBE）的原位生物修复。 MTBE的原位生物修复的主要问题包括不能建立高密度的细菌，不能保持降解细菌和MTBE之间的接触，以及细菌的扰乱和损失。 本I期项目的主要目的是评价使用生物珠作为反应材料的生物渗透屏障[BPB]的降解性能。 预计甲基叔丁基醚将被有效地生物降解至不可检测的水平。该项目的商业应用是在生物修复领域。预计这项工作的成功将对公共和私营部门与受污染场地有关的各种环境问题产生重大影响。